Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177840 · ClinicalTrials.gov registry record · Phase 1
Acupuncture to Treat Cancer-Related Fatigue in Breast Cancer Patients
A Phase 1 study of Fatigue, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 1
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT00177840: Completed Phase 1 study of Fatigue, sponsored by University of Pittsburgh.
NCT00177840 is a Phase 1 study of Fatigue that has completed, run by University of Pittsburgh. The registered enrollment target is 54 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00177840, a Phase 1 study of Fatigue, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate if acupuncture is helpful in treating cancer-related fatigue in breast cancer patients undergoing radiation therapy.
Conditions Studied
Interventions
- PROCEDURE acupuncture
Study Locations (1)
Pennsylvania
- Magee-Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-09 |
| Phase | Phase 1 |
What the finished NCT00177840 record still lists
NCT00177840 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Fatigue appearing as the primary indexed condition, and to 1 intervention - of which acupuncture is the first listed.
NCT00177840 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00177840 about?
NCT00177840 is a clinical study titled "Acupuncture to Treat Cancer-Related Fatigue in Breast Cancer Patients". This study will evaluate if acupuncture is helpful in treating cancer-related fatigue in breast cancer patients undergoing radiation therapy.
What is the current status of trial NCT00177840?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 54 participants. The study started on 2005-09. Estimated completion is 2007-09.
What conditions does trial NCT00177840 study?
This clinical trial studies the following conditions: Fatigue.
What interventions are being tested in trial NCT00177840?
The interventions under investigation include: acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT00177840?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00177840 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00177840's enrollment target sits among peer trials
54 61st of 109 higher than 48 of 109 other Fatigue trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fatigue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® Plus
RECRUITING · Phase 1
-
MitoQ for Fatigue in Multiple Sclerosis (MS)
ACTIVE NOT RECRUITING · Phase 1
-
Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate
COMPLETED · Phase 1
-
A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue
COMPLETED · Phase 1
-
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
COMPLETED · Phase 1
-
Art and Surface Electromyography (EMG)
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia